Long-Term Paclitaxel-Eluting Stent Outcomes in Elderly Patients | Zendy

Daniel E. Forman | Zendy; David A. Cox | Zendy; Stephen G. Ellis | Zendy; John M. Lasala | Zendy; John A. Ormiston | Zendy; Gregg W. Stone | Zendy; Mark Turco | Zendy; Jeanne Y. Wei | Zendy; Anita Joshi | Zendy; Keith D. Dawkins | Zendy; Donald S. Baim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Term Paclitaxel-Eluting Stent Outcomes in Elderly Patients

Author(s) -

Daniel E. Forman,

David A. Cox,

Stephen G. Ellis,

John M. Lasala,

John A. Ormiston,

Gregg W. Stone,

Mark Turco,

Jeanne Y. Wei,

Anita Joshi,

Keith D. Dawkins,

Donald S. Baim

Publication year - 2009

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.109.855221

Subject(s) - medicine , myocardial infarction , percutaneous coronary intervention , stent , target lesion , drug eluting stent , thrombosis , revascularization , bare metal , population , cardiology , surgery , restenosis , environmental health

Although drug-eluting stents have become a mainstay of percutaneous coronary intervention, information about drug-eluting stents outcomes in elderly patients is limited. Data from the paclitaxel-eluting stent (PES) trials and registries were pooled to assess PES benefits relative to advancing patient age, including comparison with bare-metal stents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research